Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation

AIMS: There is little evidence of beta-blocker treatment benefit in patients with heart failure and reduced left ventricular ejection fraction (HFREF) and atrial fibrillation (AF). We investigated the effects of bucindolol in HFREF patients with AF enrolled in the Beta-blocker Evaluation of Survival...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Kao, David P., Davis, Gordon, Aleong, Ryan, O'Connor, Christopher M., Fiuzat, Mona, Carson, Peter E., Anand, Inder S., Plehn, Jonathan F., Gottlieb, Stephen S., Silver, Marc A., Lindenfeld, JoAnn, Miller, Alan B., White, Michel, Murphy, Guinevere A., Sauer, Will, Bristow, Michael R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2013
Konular:
Treatment
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3576901/
https://ncbi.nlm.nih.gov/pubmed/23223178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurjhf/hfs181
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller